BBC
Diabetes and ADHD drugs to be tested on Alzheimer's patients in new study
Wednesday, October 21, 2026
Researchers will test diabetes and attention-deficit hyperactivity disorder medications simultaneously in Alzheimer's patients as part of a new study designed to evaluate their potential effectiveness. The parallel testing approach is intended to accelerate the identification of new treatment options for Alzheimer's disease. The specific drugs being tested, patient enrollment numbers, funding sources, and timeline for the study were not detailed in the available information.
Original reporting:
